COCP Gross Margin

The Gross Margin of Cocrystal Pharma Inc (COCP) is 21.33%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

COCP Gross Margin - Historical Value

Date	Value
2024-12-31	21.33%

COCP Gross Margin - Peers Comparison

Ticker	Name	Value
JNJ	Johnson & Johnson	69.11%
SHWZ	Medicine Man Technologies Inc	44.09%
ZTS	Zoetis Inc	70.68%
CURR	Avenir Wellness Solutions Inc	31.42%
FLWR.V	Flowr Corp	-107.60%
FONE.CN	Flower One Holdings Inc	42.63%
CANN.CN	Heritage Cannabis Holdings Corp	40.56%
XPHY.CN	Xphyto Therapeutics Corp	69.63%
ASP.TO	Acerus Pharmaceuticals Corporation	69.07%
ATXI	Avenue Therapeutics Inc	7775.20%
BAMM.CN	Body and Mind Inc	25.31%
VTRS	Viatris Inc	41.65%
BMY	Bristol-Myers Squibb Co	75.26%
ELAN	Elanco Animal Health Inc	54.88%
KHRN.V	Khiron Life Sciences Corp	18.52%
PCSA	Processa Pharmaceuticals Inc	100.00%
TBP.TO	Tetra Bio Pharma Inc	7775.20%
EYEN	Eyenovia Inc	-6749.02%
PFE	Pfizer Inc	74.33%
CRDL.TO	Cardiol Therapeutics Inc	100.00%
EBM.V	Eastwood Bio-Medical Canada Inc	64.72%
HUGE.CN	FSD Pharma Inc	-647.08%
PRPH	Prophase Labs Inc	-2.22%
RPRX	Royalty Pharma PLC	7775.20%
COOL.CN	Core One Labs Inc	-41.40%
CTLT	Catalent Inc	21.75%
ALID	Allied Corp	-335.96%
NDVA.V	Indiva Ltd	28.00%
PRFX	PainReform Ltd	7775.20%
ROMJ.V	Rubicon Organics Inc	58.38%
EVOK	Evoke Pharma Inc	96.52%
LLY	Eli Lilly and Co	81.31%
MRK	Merck & Co Inc	77.09%